렌티바이러스 벡터 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상되며, 2029년에는 15.3%의 CAGR로 294억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 맞춤형 의료의 성장, 유전자 편집 혁신, 희귀 질환 치료 수요, 렌티바이러스 벡터 채택, 유전체 의료 자금 조달, 제조 확장성에 대한 관심에 기인합니다. 예측 기간의 주요 동향으로는 연구개발 확대, CAR-T 세포 치료로의 통합, 차세대 벡터 개발, 백신 개발로의 채택, 생산 기술 개발 등을 꼽을 수 있습니다.
만성질환의 유병률 증가는 렌티큘러 바이러스 벡터 시장의 성장을 견인할 것으로 예상됩니다. 만성질환은 서서히 발병하여 수년 또는 평생 동안 지속되는 장기적인 건강 상태입니다. 이러한 질병의 유병률 증가는 인구 고령화, 건강에 해로운 생활습관, 도시화, 환경적 영향 등의 요인에 기인합니다. 렌티바이러스 벡터는 만성질환에 대한 백신 및 치료 전략을 개발하고, 미충족 의료 수요를 충족시키며, 환자 예후를 개선할 수 있는 다재다능하고 효율적인 도구를 제공합니다. 예를 들어, 2024년 9월 영국에 기반을 둔 심혈관 연구 자선단체인 영국심장재단(British Heart Foundation)은 영국에서 약 760만 명이 심장 및 순환기 질환을 앓고 있으며, 남성 400만 명, 여성 360만 명이 이 질환을 앓고 있다고 보고했습니다. 이러한 질병은 영국 전체 사망의 약 27%를 차지하며, 연간 17만 명 이상, 하루 약 480명, 즉 약 3분에 1명꼴로 사망에 이르게 합니다. 이처럼 만성질환의 유병률 증가가 렌티바이러스 벡터 시장의 성장을 견인하고 있습니다.
렌티바이러스 벡터 시장의 주요 업체들은 세포 기반 면역 종양학 치료를 위한 렌티바이러스 벡터 제조의 효율성과 견고성을 높이기 위해 LV 벡터 제조 플랫폼의 발전에 주력하고 있습니다. 2023년 5월 Yposkesi sk pharmteco가 발표한 LentiSure는 세포 기반 면역종양학 치료를 위한 렌티바이러스 벡터 제조를 최적화하도록 설계된 혁신적인 플랫폼입니다. LentiSure는 세포 및 유전자 치료 분야에서 확장 가능하고 신뢰할 수 있는 바이러스 벡터 생산 기술에 대한 수요 증가에 대응하고 렌티바이러스 생산의 탄력성과 효율성을 강화하는 것을 목표로 하고 있습니다. 세포 기반 면역항암제 개발 및 상용화를 가속화하여 만성질환과 관련된 미충족 의료 수요를 충족시킬 것으로 기대됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 렌티바이러스 벡터 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 렌티바이러스 벡터 시장 : 성장률 분석
- 세계의 렌티바이러스 벡터 시장 실적 : 규모와 성장, 2019-2024
- 세계의 렌티바이러스 벡터 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 렌티바이러스 벡터 전체 시장(TAM)
제6장 시장 세분화
- 세계의 렌티바이러스 벡터 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 키트
- 시약 및 소모품
- 세계의 렌티바이러스 벡터 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 암
- 유전성 질환
- 감염증
- 수의 질환
- 기타 적응증
- 세계의 렌티바이러스 벡터 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 바이오테크놀러지 기업
- 제약회사
- 조사 업무 수탁 기관(CRO)
- 학술연구기관
- 세계의 렌티바이러스 벡터 시장, 키트 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 렌티바이러스 도입 키트
- 렌티바이러스 패키징 키트
- 렌티바이러스 벡터 제작 키트
- 세계의 렌티바이러스 벡터 시장, 시약 및 소모품 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 렌티바이러스 패키징 시약
- 렌티바이러스 벡터 농축 시약
- 렌티바이러스 벡터용 트랜스펙션 시약
제7장 지역별·국가별 분석
- 세계의 렌티바이러스 벡터 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 렌티바이러스 벡터 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 렌티바이러스 벡터 시장 : 경쟁 구도
- 렌티바이러스 벡터 시장 : 기업 개요
- Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Thermo Fisher Scientific Inc
- AstraZeneca plc
- Novartis AG
- GlaxoSmithKline plc(GSK)
- Eli Lilly and Company
- Agilent Technologies Inc
- Amgen Inc
- Merck KGaA
- Lonza Group Ag
- Cytiva
- Charles River Laboratories
- Bio-Rad Laboratories Inc
- Promega Corporation
- Takara Bio Inc
- Sino Biological Inc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 렌티바이러스 벡터 시장 2029 : 새로운 기회를 제공하는 국가
- 렌티바이러스 벡터 시장 2029 : 새로운 기회를 제공하는 부문
- 렌티바이러스 벡터 시장 2029 : 성장 전략
제36장 부록
ksm
A lentiviral vector is a viral vector derived from lentiviruses, a subgroup of retroviruses known for their ability to integrate genetic material into the DNA of host cells. These vectors are widely used in molecular biology and gene therapy applications to deliver genetic material into target cells for purposes such as gene expression, gene silencing, or genetic modification.
Key products in the lentiviral vector category include kits, reagents, and consumables. Lentiviral vector kits provide a comprehensive set of tools and components necessary for generating and manipulating lentiviral vectors. These kits find application across various indications such as cancer, genetic disorders, infectious diseases, veterinary diseases, and more. Users of lentiviral vector products include biotechnology companies, pharmaceutical companies, contract research organizations (CROs), as well as academic and research institutes.
The lentiviral vector market research report is one of a series of new reports from The Business Research Company that provides lentiviral vector market statistics, including lentiviral vector industry global market size, regional shares, competitors with a lentiviral vector market share, detailed lentiviral vector market segments, market trends and opportunities, and any further data you may need to thrive in the lentiviral vector industry. This lentiviral vector market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The lentiviral vector market size has grown rapidly in recent years. It will grow from $14.37 billion in 2024 to $16.62 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to prevalence of genetic disorders, gene delivery demand, biotech and pharma expansion, clinical trial investment, regulatory approvals.
The lentiviral vector market size is expected to see rapid growth in the next few years. It will grow to $29.41 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to personalized medicine growth, gene editing innovations, rare disease therapy demand, lentiviral vector adoption, genomic medicine funding, manufacturing scalability focus. Major trends in the forecast period include expansion of research and development, integration in CAR-T cell therapy, development of next-generation vectors, adoption in vaccine development, development of production technologies.
The rising prevalence of chronic diseases is expected to drive the growth of the lentiviral vectors market. Chronic diseases are long-term health conditions that develop gradually and persist for years or even a lifetime. The increasing prevalence of these diseases is attributed to factors such as aging populations, unhealthy lifestyles, urbanization, and environmental influences. Lentiviral vectors provide versatile and efficient tools for developing vaccines and treatment strategies for chronic diseases, addressing unmet medical needs and improving patient outcomes. For instance, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with 4 million males and 3.6 million females living with these conditions. These diseases are responsible for around 27% of all deaths in the UK, leading to over 170,000 deaths annually, or about 480 deaths per day-roughly one death every three minutes. Thus, the increasing prevalence of chronic diseases is driving the growth of the lentiviral vectors market.
Key players in the lentiviral vectors market are concentrating their efforts on advancing LV vector production platforms to enhance the efficiency and robustness of lentivirus vector manufacturing for cell-based immuno-oncology therapies. One such innovative platform is LentiSure, designed to optimize the production of lentiviral vectors for cell-based immuno-oncology therapies. Launched by Yposkesi sk pharmteco in May 2023, LentiSure aims to bolster the resilience and efficiency of lentivirus production, catering to the escalating demand for scalable and reliable viral vector manufacturing technologies in cell and gene therapies. With features such as consistent product quality and high productivity, LentiSure offers promise in accelerating the development and commercialization of cell-based immuno-oncology therapies, addressing the unmet medical needs associated with chronic diseases.
In September 2024, Kyverna Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, entered into a license and supply agreement for the LentiVector platform with Oxford Biomedica. This collaboration allows Kyverna to utilize Oxford Biomedica's proprietary lentiviral vector technology in the development of gene therapies, particularly targeting autoimmune diseases. The agreement supports the expansion and innovation of the lentiviral vector market by ensuring a scalable and reliable supply of vectors to meet the growing demand. Oxford Biomedica is a UK-based biotechnology company specializing in providing lentiviral vector platforms.
Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag, Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi
North America was the largest region in the lentiviral vector market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the lentiviral vector market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lentiviral vector market consists of sales of 3rd generation lentiviral vectors, Lenti-ORF clones, and lentiviral particles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lentiviral Vector Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lentiviral vector market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lentiviral vector ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lentiviral vector market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Kits; Reagents And Consumables
- 2) By Indication: Cancer; Genetic Disorder; Infectious Disease; Veterinary Disease; Other Indications
- 3) By End User: Biotechnology Companies; Pharmaceutical Companies; Contract Research Organization (CRO); Academic And Research Institutes
- Subsegments:
- 1) By Kits: Lentiviral Transduction Kits; Lentiviral Packaging Kits; Lentiviral Vector Production Kits
- 2) By Reagents and Consumables: Lentiviral Packaging Reagents; Lentiviral Vector Concentration Reagents; Transfection Reagents for Lentiviral Vectors
- Companies Mentioned: Pfizer Inc; AbbVie Inc; Bayer AG; Sanofi SA; Bristol Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lentiviral Vector Market Characteristics
3. Lentiviral Vector Market Trends And Strategies
4. Lentiviral Vector Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Lentiviral Vector Growth Analysis And Strategic Analysis Framework
- 5.1. Global Lentiviral Vector PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Lentiviral Vector Market Growth Rate Analysis
- 5.4. Global Lentiviral Vector Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Lentiviral Vector Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Lentiviral Vector Total Addressable Market (TAM)
6. Lentiviral Vector Market Segmentation
- 6.1. Global Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Kits
- Reagents And Consumables
- 6.2. Global Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer
- Genetic Disorder
- Infectious Disease
- Veterinary Disease
- Other Indications
- 6.3. Global Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biotechnology Companies
- Pharmaceutical Companies
- Contract Research Organization (CRO)
- Academic And Research Institutes
- 6.4. Global Lentiviral Vector Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lentiviral Transduction Kits
- Lentiviral Packaging Kits
- Lentiviral Vector Production Kits
- 6.5. Global Lentiviral Vector Market, Sub-Segmentation Of Reagents and Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lentiviral Packaging Reagents
- Lentiviral Vector Concentration Reagents
- Transfection Reagents for Lentiviral Vectors
7. Lentiviral Vector Market Regional And Country Analysis
- 7.1. Global Lentiviral Vector Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Lentiviral Vector Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Lentiviral Vector Market
- 8.1. Asia-Pacific Lentiviral Vector Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lentiviral Vector Market
- 9.1. China Lentiviral Vector Market Overview
- 9.2. China Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lentiviral Vector Market
- 10.1. India Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lentiviral Vector Market
- 11.1. Japan Lentiviral Vector Market Overview
- 11.2. Japan Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lentiviral Vector Market
- 12.1. Australia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lentiviral Vector Market
- 13.1. Indonesia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lentiviral Vector Market
- 14.1. South Korea Lentiviral Vector Market Overview
- 14.2. South Korea Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lentiviral Vector Market
- 15.1. Western Europe Lentiviral Vector Market Overview
- 15.2. Western Europe Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lentiviral Vector Market
- 16.1. UK Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lentiviral Vector Market
- 17.1. Germany Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lentiviral Vector Market
- 18.1. France Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lentiviral Vector Market
- 19.1. Italy Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lentiviral Vector Market
- 20.1. Spain Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lentiviral Vector Market
- 21.1. Eastern Europe Lentiviral Vector Market Overview
- 21.2. Eastern Europe Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lentiviral Vector Market
- 22.1. Russia Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lentiviral Vector Market
- 23.1. North America Lentiviral Vector Market Overview
- 23.2. North America Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lentiviral Vector Market
- 24.1. USA Lentiviral Vector Market Overview
- 24.2. USA Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lentiviral Vector Market
- 25.1. Canada Lentiviral Vector Market Overview
- 25.2. Canada Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lentiviral Vector Market
- 26.1. South America Lentiviral Vector Market Overview
- 26.2. South America Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lentiviral Vector Market
- 27.1. Brazil Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lentiviral Vector Market
- 28.1. Middle East Lentiviral Vector Market Overview
- 28.2. Middle East Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lentiviral Vector Market
- 29.1. Africa Lentiviral Vector Market Overview
- 29.2. Africa Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lentiviral Vector Market Competitive Landscape And Company Profiles
- 30.1. Lentiviral Vector Market Competitive Landscape
- 30.2. Lentiviral Vector Market Company Profiles
- 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Lentiviral Vector Market Other Major And Innovative Companies
- 31.1. Thermo Fisher Scientific Inc
- 31.2. AstraZeneca plc
- 31.3. Novartis AG
- 31.4. GlaxoSmithKline plc (GSK)
- 31.5. Eli Lilly and Company
- 31.6. Agilent Technologies Inc
- 31.7. Amgen Inc
- 31.8. Merck KGaA
- 31.9. Lonza Group Ag
- 31.10. Cytiva
- 31.11. Charles River Laboratories
- 31.12. Bio-Rad Laboratories Inc
- 31.13. Promega Corporation
- 31.14. Takara Bio Inc
- 31.15. Sino Biological Inc
32. Global Lentiviral Vector Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Lentiviral Vector Market
34. Recent Developments In The Lentiviral Vector Market
35. Lentiviral Vector Market High Potential Countries, Segments and Strategies
- 35.1 Lentiviral Vector Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Lentiviral Vector Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Lentiviral Vector Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
